Guest Column
China's losers from healthcare reform
- Published 09 Sep 2010
Jonathan Zifferblatt, managing director of General Biologic, talks on the challenges facing China's healthcare and pharmaceutical industry following the implementation of healthcare reform.
Healthcare reform, when announced by the Chinese government in 2008, met with predictably mixed reactions from various stakeholders in China’s medical and pharmaceutical sectors.
Login
If you are already a subscriber, please log in below.
China Confidential Funds
China Confidential Funds, a new research service launched by FT China Confidential, is dedicated to illuminating the mainland fund industry. Our team of fund industry experts in Shanghai search out the interesting trends in fund performance, strategy, interactions with overseas funds, regulatory changes, distribution and management. We also use a proprietary system to track the emerging flows of Chinese money. Click here to find out more.
Other Articles on this Issue
-
Financial China
Select financial charts
Credit powers consumer activity
-
Macro View
Optimistic consumers
-
The Big Call
Survey shows strong consumer demand
-
Consumer China
Urban upper income group – big spenders, international tastes
Urban middle income group – a Nokia, a Volkswagen and an eye on investments
Rural migrant workers – buying domestic brands
Rural discretionary consumer family – emerging from subsistence
Urban low income group – self-improvers on the lowest urban rung
Paid-for education – demand for English language tuition remains buoyant
Mobile phones – Nokia losing share to Blackberry and Apple
Health insurance – popularity of 'supplementary' insurance boosts key firms
Cars – high-end models thrive as low-end stall
Laptops and white goods – Apple gains on Lenovo, Haier strong in white goods
-
The Best of Chinese Commentators
Is car production reaching overcapacity?
China's vacant housing
-
Funds Data
Flows to Taiwan falter
- View issue
© The Financial Times Ltd 2012 'China Confidential', 'FT' and 'Financial Times' are trade marks of The Financial Times Ltd.
A Financial Times Service
v5.0.27 running on ftbwebw-sun-01-z1
